Dr. Patil Tejas, MD
Claim this profileStudies Lung Cancer
Studies Non-Small Cell Lung Cancer
1 reported clinical trial
1 drug studied
Area of expertise
1Lung Cancer
Stage III
RET positive
Stage IV
2Non-Small Cell Lung Cancer
Stage III
RET positive
Stage IV
Clinical Trials Patil Tejas, MD is currently running
More about Patil Tejas, MD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Patil Tejas, MD has experience with
- Amivantamab
Breakdown of trials Patil Tejas, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Patil Tejas, MD specialize in?
Patil Tejas, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are RET positive.
Is Patil Tejas, MD currently recruiting for clinical trials?
Yes, Patil Tejas, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Patil Tejas, MD has studied deeply?
Yes, Patil Tejas, MD has studied treatments such as Amivantamab.
What is the best way to schedule an appointment with Patil Tejas, MD?
Apply for one of the trials that Patil Tejas, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.